Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-19

Clinical Trial Update: Augmentation of Psychotherapy With D-Cycloserine in Agoraphobia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating augmentation of psychotherapy with D-Cycloserine for agoraphobia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • D-cycloserine (D-cycloserine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Agoraphobia | Phase 2 | Status: COMPLETED